In December 2005, Eli Lilly and Organization agreed to plead guilty and shell out $36 million in connection with the unlawful advertising from the drug.[264] Income Associates were being qualified to advertise Evista for breast most cancers and heart problems, to prompt or bait thoughts by Healt